NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.
Letter to Congressional Leadership on Parity
Letter to Speaker Pelosi and Leader Schumer, urging continued support for civil monetary penalty authority for the U.S. Department of Labor to enforce the Paul Wellstone and Pete Domenici Mental Health Parity and Addiction Equity Act of 2008 (MHPAEA).
Letter to FDA on Medication Access
Letter to the FDA regarding reporting and treatment recommendation updates to the Clozapine Risk Evaluation and Mitigation Strategies (REMS) surveillance system.
Letter to CMS Administrator on Medicaid
Letter to CMS Administrator Brooks-LaSure, thanking the CMS for the agency’s recent decision to remove a financial barrier to Medicaid coverage by rejecting and phasing out premiums in Section 1115 waivers.
Letter to Congressional Leadership on Health Coverage
Letter to Speaker Pelosi and Leader Schumer, urging Congress to permanently expand ACA programs including the enhanced advance premium tax credits (APTCs) and close the Medicaid coverage gap in the Fiscal Year 2022 budget reconciliation process.
Regulatory Comment to HHS Secretary on Medicaid & Criminal Justice
Regulatory comments to HHS Secretary Becerra, commenting on the Massachusetts Medicaid proposal that would extend postpartum Medicaid coverage; expanding Medicaid
coverage and services for justice-involved individuals; and continue and expand support for the behavioral health workforce.
Letter to the Biden Administration on Health Coverage
Letter to HHS Secretary Becerra, IRS Commissioner Rettig, CMS Administrator Brooks-LaSure, and DOL Acting Assistant Secretary Khawar asking that the agencies issue new regulations as soon as possible limiting the sale and availability of short-term, limited-duration (“STLD”) health insurance.